[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 876 Introduced in House (IH)]
<DOC>
117th CONGRESS
2d Session
H. RES. 876
Expressing the sense that the process behind Operation Warp Speed
should be integrated within operations at the Food and Drug
Administration.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 19, 2022
Mr. Burgess submitted the following resolution; which was referred to
the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Expressing the sense that the process behind Operation Warp Speed
should be integrated within operations at the Food and Drug
Administration.
Resolved, That it is the sense of Congress that the Commissioner of
Food and Drugs should--
(1) to the extent scientifically and legally possible,
integrate the process behind Operation Warp Speed into
operations at the Food and Drug Administration;
(2) issue guidance identifying ways that drug and
biological product innovation and development can be
accelerated through clinical trials and the approval and
licensure processes;
(3) for purposes of accelerating the approval of new drugs
and biological products, cross-reference applicable safety and
scientific data from approved drugs and licensed biological
products; and
(4) collect interim data that would allow for parallel
assessments of the safety and effectiveness of multiple drugs
and biological products and the parallel approval or licensure
of multiple drugs and biological products, including through
the conduct of concurrent clinical trials.
<all>